| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2319544C Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 06/29/2006 | WO2006067502A1 Treatment of inflammatory diseases |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006066899A1 Novel thrombin inhibitors |
| 06/29/2006 | WO2006066878A1 Prevention of thrombus formation and/or stabilization |
| 06/29/2006 | WO2006066441A1 A fibrinolysin of agkistrodon acutus venom and its usage |
| 06/29/2006 | WO2006054298A3 Glycogen synthase kinase-3 inhibitors |
| 06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
| 06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142268 1,4,5,6-tetrahydroimidazo[4,5-d]benzazepine derivative or salt thereof |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142209 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 06/29/2006 | US20060142195 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141476 Growth arrest homeobox gene |
| 06/29/2006 | US20060141018 Hemostatic compositions and methods for controlling bleeding |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140907 Central airway administration for systemic delivery of therapeutics |
| 06/29/2006 | CA2591786A1 Prevention of thrombus formation and/or stabilization |
| 06/29/2006 | CA2591129A1 Treatment of inflammatory diseases |
| 06/28/2006 | EP1674468A1 Polymorphs of clopidogrel hydrobromide |
| 06/28/2006 | EP1674464A1 Novel thrombin inhibitors |
| 06/28/2006 | EP1674454A1 SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 06/28/2006 | EP1254159B9 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 06/28/2006 | EP0914103B1 Treatment of a hemoglobinopathy |
| 06/28/2006 | CN1793104A Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof |
| 06/28/2006 | CN1792248A Cooked meat with donkey-hide gelatin for health-care, moistening-skin, improving-immunity, benefit to brain and retarding-senium |
| 06/28/2006 | CN1792246A Nutrient food with functions of improving iron deficiency anemia and improving skin moisture and oil |
| 06/28/2006 | CN1792245A Donkey-hide gelatin instant granule with Chinese date taste, and its prepn. method |
| 06/28/2006 | CN1261450C Antithrombotic compounds |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/28/2006 | CN1261159C Freeze dried powder injection of hirudin and its preparation method |
| 06/28/2006 | CN1261109C Compound formulation of adjusting, curing or improving blood function |
| 06/28/2006 | CN1261105C Encephalic proteolytic products of compound Piracetam and its preparation method |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067489 Hematopoietic stimulation |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | CA2253833C Derivatives of k5 polysaccharide having high anticoagulant activity |
| 06/22/2006 | WO2006065853A2 Crystalline forms of a factor xa inhibitor |
| 06/22/2006 | WO2006064957A1 Amide compound and thrombopoietin receptor activator |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006063837A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 06/22/2006 | WO2006063515A1 Use of radix sanguisorbae and its extract for preparing medicament to increase rbc and hemoglobin |
| 06/22/2006 | WO2006063486A1 A fibrinolysin of agkistrodon acutus venom and its usage |
| 06/22/2006 | WO2006063465A1 Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135613 Carboxamides derivatives |
| 06/22/2006 | US20060135611 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/22/2006 | US20060135607 Drug for improving prognosis for subarachnoid hemorrhage |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135560 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135529 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 06/22/2006 | US20060134769 Process for producing a virus-inactivated thrombin preparation |
| 06/22/2006 | US20060134167 Administering to the cardiac tissue an angiogenic thrombin derivative peptide and/or inhibiting vascular occulsion or restenosis and stimulating revascularization |
| 06/22/2006 | US20060134069 Erythrocytic cells and method for preserving cells |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2589886A1 Crystalline forms of a factor xa inhibitor |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1670739A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 06/21/2006 | EP1536822B1 Stable pharmaceutical composition comprising erythropoietin |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0909564B1 Erythropoietin solution preparation stabilized with amino acids |
| 06/21/2006 | CN1791614A Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme |
| 06/21/2006 | CN1791601A Azaindole-derivatives as factor Xa inhibitors |
| 06/21/2006 | CN1791598A Benzimidazole-derivatives as factor Xa inhibitors |
| 06/21/2006 | CN1788785A Pharmaceutical composition for treating and preventing thrombus and its preparation method |
| 06/21/2006 | CN1788769A Sumatra dragonsblood soft capsule and its preparation method |
| 06/21/2006 | CN1788758A Use of traditional Chinese medicine garden burnet and its extract in preparing drug for raising red cell and blood hemoglobin |